Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0042109 (
urticaria
)
6,569
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Serum immunoglobulins, complement and
alpha 1-antitrypsin
were assayed in forty-eight patients with chronic urticaria. Thirteen cases had chronic cold
urticaria
and thirty-two had chronic idiopathic
urticaria
. Elevated mean serum IgM was found in chronic cold
urticaria
. Seven patients had partial immunoglobulin deficiencies. IgE was elevated in sixteen cases of chronic idiopathic and in two with chronic cold
urticaria
. Eight patients had depressed serum total haemolytic complement activity. Low C3 and normal C4 serum protein concentrations in four cases suggested alternative complement pathway activation. Twenty of forty-six patients were atopic, although specific allergies responsible for the
urticaria
were not identified in any of them.
alpha 1-antitrypsin
levels were normal in all patients. The data suggest that the aetiology and pathogenesis of chronic urticarias in this study are heterogeneous. No evidence of abnormality of the protease inhibitor system in either chronic idiopathic or chronic cold
urticaria
was found.
...
PMID:Immunological parameters and alpha 1-antitrypsinin chronic urticaria. 31 14
Proteins of the serpin family (serine protease inhibitor) control key steps in the inflammatory, coagulation and complement systems. C1-inhibitor deficiency predisposes to hereditary angioneurotic oedema, and other serpins control proteolytic enzymes that may cause complement activation or the forming of oedema. We investigated whether deficiency of proteins of the serpin family may predispose to cold
urticaria
and therefore screened 7 male patients with severe cold
urticaria
for the presence of deficiency alleles of some of the members of the serpin antiprotease family. There were no findings of C1-inhibitor,
alpha 1-antitrypsin
, alpha 2-antiplasmin, antithrombin III, tissue plasminogen activator inhibitor or thyroxine binding protein deficiency. The prevalence of heterozygous alpha 1-antichymotrypsin deficiency was significantly higher than expected (prevalence ratio 25.8 (95% confidence interval 6.0-112), p < 0.0001). This finding is in concert with previous studies that have shown lower mean levels of alpha 1-antichymotrypsin among patients with cold
urticaria
and suggests that heterozygous deficiency of this antiprotease, which controls neutrophil cathepsin G and mast cell chymase may predispose to cold
urticaria
. The present series is, however, small and the results need confirmation in larger materials.
...
PMID:Heterozygous alpha 1-antichymotrypsin deficiency may be associated with cold urticaria. 148 47
A group of 281 patients with chronic urticaria was classified into various subtypes and compared with 357 healthy controls for PI types of alpha1-antitrypsin. Total
alpha 1-antitrypsin
was measured by the Mancini technique, and PI types were determined by isoelectric focusing. The MZ phenotype and the Z gene frequency were significantly more frequent in the
urticaria
group. The Z gene predominated in the groups with cold
urticaria
and acquired angio-oedema. The total group of chronic urticaria patients showed a significant decrease in total
alpha 1-antitrypsin
compared with the control group (P less than 0.03). Deficiencies in
alpha 1-antitrypsin
may predispose to the development of certain types of
urticaria
and angio-oedema.
...
PMID:Alpha 1-antitrypsin deficiency and PI typing in patients with chronic urticaria. 387 51